HeadPulse Large Vessel Occlusion Validation Study

Sponsor
MindRhythm, Inc. (Industry)
Overall Status
Enrolling by invitation
CT.gov ID
NCT05719272
Collaborator
University at Buffalo (Other), The Cooper Health System (Other)
50
2
6.4
25
3.9

Study Details

Study Description

Brief Summary

Acute ischemic stroke (AIS) is a treatable disease if patients can be transported and treated at stroke centers. MindRhythm, Inc (sponsor) has developed an investigational medical device that is designed for prehospital field use to differentiate the two major forms of acute ischemic stroke, namely Large Vessel Occlusion (LVO) stroke and non-large vessel occlusion stroke. The intended use is for paramedics to decide which destination hospital is best for the patient based on the device result. Large vessel occlusion stroke patients should be brought directly to comprehensive stroke centers which can perform thrombectomy, and non-large vessel occlusion stroke should be brought to primary stroke centers. Use of the device will save time getting the patient to thrombectomy and all others to intravenous thrombolytics or blood thinners that clear clots improves outcomes for all patients.

The Harmony 5000 device manufactured by MindRhythm has been tested in the pre-hospital environment, but because large vessel occlusion stroke is less common than non-large vessel occlusion stroke, the sponsor wants to obtain additional recordings from patients with large vessel occlusion to better refine their algorithms. Investigators will perform acute recordings on patients who arrive at the medical center who have computed tomography angiography studies showing the presence of large vessel occlusion stroke stroke, and on patients transferred to the angiography suite for thrombectomy. Recordings are performed in parallel to standard workflow of large vessel occlusion stroke patients so the research will not delay treatments.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Eligible participants will be 18 years of age plus with known large vessel occlusion who have been transferred to the emergency department. Recordings can be made just prior to the thrombectomy or within 2 hours of computed tomography angiography and no thrombectomy performed.

    Participants will be excluded if they have an open wound on the scalp or are prisoners.

    The MindRhythm Harmony headset will be placed on the subject (a total of 50 subjects) along with ECG leads and a 3 minute recording of the HeadPulse (cranial waveform) will be performed while the subject remains as still as possible. The data will then be transferred to MindRhythm for analysis and ultimate improvement of the diagnostic stroke algorithm.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    50 participants
    Observational Model:
    Case-Only
    Time Perspective:
    Cross-Sectional
    Official Title:
    HeadPulse Large Vessel Occlusion Validation Study
    Actual Study Start Date :
    Nov 16, 2022
    Anticipated Primary Completion Date :
    May 1, 2023
    Anticipated Study Completion Date :
    May 30, 2023

    Outcome Measures

    Primary Outcome Measures

    1. HeadPulse Waveform Data [90 seconds]

      Waveform data associated with the changes in brain function as a result of the cranial effect of the. cardiac cycle

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Inclusion Criteria:
    • adult patient Known LVO (transferred or arrived at our ED) ICA-T, M1, M2 or Basilar Artery Recording can be made just prior to thrombectomy, or within 2 hours of CTA and no thrombectomy performed
    Exclusion Criteria:
    • Prisoner Open scalp wound

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Cooper University Hospital Camden New Jersey United States 08103
    2 University at Buffalo Buffalo New York United States 14206

    Sponsors and Collaborators

    • MindRhythm, Inc.
    • University at Buffalo
    • The Cooper Health System

    Investigators

    • Principal Investigator: Paul Lovoi, PhD, CTO of Sponsor

    Study Documents (Full-Text)

    More Information

    Publications

    None provided.
    Responsible Party:
    MindRhythm, Inc.
    ClinicalTrials.gov Identifier:
    NCT05719272
    Other Study ID Numbers:
    • EPISODE_LVO_MR1
    First Posted:
    Feb 8, 2023
    Last Update Posted:
    Feb 8, 2023
    Last Verified:
    Feb 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Feb 8, 2023